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Abstract: Rapid identification and characterization of multidrug-resistant Klebsiella pneumoniae strains
is essential to diagnose severe infections in patients. In clinical routine practice, K. pneumoniae is
frequently identified and characterized for outbreak investigation. Pulsed-field gel electrophoresis or
multilocus sequence typing could be used, but, unfortunately, these methods are time-consuming,
laborious, expensive, and do not provide any information about the presence of resistance and
virulence genes. In recent years, the decreasing cost of next-generation sequencing and its easy
use have led to it being considered a useful method, not only for outbreak surveillance but also
for rapid identification and evaluation, in a single step, of virulence factors and resistance genes.
Carbapenem-resistant strains of K. pneumoniae have become endemic in Italy, and in these strains
the ability to form biofilms, communities of bacteria fixed in an extracellular matrix, can defend the
pathogen from the host immune response as well as from antibiotics, improving its persistence in
epithelial tissues and on medical device surfaces.
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1. Introduction
Klebsiella pneumoniae, bacteria of the family Enterobacteriaceae, is a main human
pathogen causing hospital- and community-acquired infections such as bacteremia, urinary
tract infections, pneumonia, and pyogenic liver abscesses [1,2].
Some K. pneumoniae isolates have been shown to be resistant to first-line antibiotics.
Due to the spread of carbapenem-resistant K. pneumoniae (CR-Kp), this pathogen represents
one of the microorganisms constituting an urgent threat to human health. Antimicrobial
resistance to carbapenem is commonly related to the spread of transmissible plasmids,
and the acquisition of resistance genes normally occurs by horizontal gene transfer [3].
Antimicrobial resistance plasmids have been called “epidemic resistance plasmids” because
of their tendency to acquire resistance genes and the rapid diffusion among members of
the family Enterobacteriaceae. Antimicrobial resistance determinants of epidemic plasmids
offer a benefit to high-risk clones and are probably essential to their spread [4].
Resistance to carbapenems involves multiple mechanisms, including the following:
alterations in outer membrane permeability mediated by the loss of porins, upregulation
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of efflux systems along with hyperproduction of AmpC β-lactamases, extended-spectrum
β-lactamases (ESBLs), or more commonly, the production of carbapenemases.
Twenty-two different KPC (Klebsiella pneumoniae carbapenemase) enzyme variants
have been identified. KPC β-lactamases can hydrolyze all β-lactams, including carbapen-
ems, cephalosporins, cephamycins, monobactams, and clavulanic acid.
KPCs have been found in many Gram-negative species, including both Enterobac-
teriaceae and non-fermenters. KPCs are frequently found in K. pneumoniae associated
with nosocomial infections, such as urinary tract infections, septicemia, pneumonia, and
intra-abdominal infections.
The global spread of CR-Kp has been largely associated with “high-risk” carbapenemase-
producing clones, mostly sequence type (ST) 258 and its related variants (clonal complex
258 (CC258)). However, in healthcare facilities, the spread of CR-Kp isolates other than
ST258 has already been described [5–7]. In the geographic area of Palermo, Italy, CC258 is
still prevalent; however, several other STs (e.g., ST307, ST395, ST392, ST348, ST405, and
ST101) are emerging and circulating. This indicates a more complex polyclonal spread of
K. pneumoniae carbapenemase producers [8–10].
For pathogen survival, other than the acquisition of resistance, virulent traits are
also important, and some reports suggest that they may have an essential role in the
pathogenesis of K. pneumoniae infections [11,12]. However, the most important virulence
factors responsible for K. pneumoniae pathogenesis are capsular polysaccharides, which can
collaborate to form biofilm [13,14], supporting the bacterial attachment to living or abiotic
surfaces and preventing the effects of antimicrobial agents [15,16].
Using a next-generation sequencing (NGS) approach, it is possible to obtain molecular
characterization in terms of genotyping and analyses of the genetic repertoire, including
antibiotic resistance, virulence-related factors, and plasmid content of strains [17,18].
On the basis of this indication, the determination of genetic diversity for dominant
species identification and complete knowledge of biofilm formation is necessary for stop-
ping the spread of infection in hospitals and for the control and management of associated
infections. In addition, knowing the principal genotype of isolates can aid in the identifica-
tion of the cause of an infection in order to realize protective actions and infection control.
The purpose of this study was to report the draft sequence of a carbapenemase- and
biofilm-producing K. pneumoniae strain belonging to ST405 isolated from a clinical sample.
We hypothesize that despite the in vitro resistance to the antibiotic therapy used, the
infection could be resolved by the early use of combined therapy at high doses of antibiotics
and by the immediate removal of the peripherally inserted central catheter (PICC).
2. Results
2.1. Molecular Genotyping
The in silico multilocus sequence typing (MLST) analysis revealed that the strain
belonged to ST405. The image below shows the ST405 with respect to the carbapenem-
resistant K. pneumoniae ST collected from March 2014 to March 2016 at the Azienda Os-
pedaliera Universitaria Policlinico “P. Giaccone” of Palermo [13].
In Figure 1, we report a radial diagram showing each sequence type (ST) represented
by a circle with the numbers indicating the locus differences between the STs. The numbers
in Table 1 show the corresponding housekeeping gene alleles for each ST.
A resistome study confirmed the susceptibility test results, and genes encoding for
factors associated with resistance to the main classes of antibiotic were identified in silico.
In particular, we found the presence of genes associated with resistance to beta-lactamase
(blaKPC-3, blaCTX-M-15, blaOXA-1, blaSHV-76, blaTEM-1), aminoglycoside (aac(3) lla-c-2, aac(6′)-Ib-cr,
aph(3)pp Ib-2, aph(6) Id-1), heavy metal (pcoA-2, pcoB-3, pcoC-1, pcoD-2, pcoE-1, pcoR-1, pcoS-2,
silC-3, silE-3, silR-2, silS-2), quinolone (gyrA-4, gyrB-1, parC-2, qnrB-1), and efflux systems
and regulators (acrR-1, envR-15, fis-1, marA-2, marR-1, oqxR-4, rob-21, sdiA-6, soxR-2, soxS-4).
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Figure 1. A radial diagram created using goeBURST.
Table 1. Housekeeping gene alleles for each sequence type (ST).
Locus Putative Functionof Gene Lengh (bp) ST 258 ST 512 ST 395 ST 101 ST 392 ST 348 ST 307 ST 405





450 3 54 3 2 3 2 4 2
mdh Malate deydrogenase 477 1 1 2 1 6 20 2 62
Pgi Phosphoglucoseisomerase 432 1 1 4 5 1 10 52 3
pho E Phosphoporine E 420 1 1 1 4 7 12 1 10
inf B Translation initiationfactor 2 318 3 3 1 6 4 1 1 1
ton B Periplasmic energytrasducer 414 79 79 4 6 40 16 7 110
The screening for (putative) virulence profile revealed the presence of a variety of
virulence-associated genes. In particular, genes encoding for type-3 fimbriae, biofilm
formation and host cell adherence (mrkA-4, mrkB-1, mrkF-38, mrkH-15, mrkI-18, mrkJ-1, and
cps cluster genes, wzi-143 and wzc-937, associated with the K type (K) and the K locus (KL)-
151), the fyuA yersiniabactin receptor, irp1-148 and irp2-145 aerobactin, kvgA-2 regulator
system component, yersiniabactin system (ybtA-1, ybtA-39, ybtE-69, ybtP-4, ybtQ-60, ybtS-6,
ybtT-39, ybtU-2, ybtX-62), and microcin E492 system components (mceA-1, mceC-1, mceD-3,
mceE-2, mceH-5) were detected.
The PlasmidFinder (http://www.genomicepidemiology.org) (accessed on 10 May
2021) database was used to describe the replicon plasmid content type of the K. pneumo-
niae isolate. Three plasmid Inc types were identified: IncFII(K) (CP000648), IncFIB(pQil)
(JN233705), and IncFIB(K)-Kpn3 (JN233704). However, the intrinsic limits of short-read
technologies (e.g., Illumina) in the WGS (Whole Genome Sequencing) method did not
allow us to accurately reconstruct the genomic context surrounding the repeated sequences,
typically related to antibiotic resistance and virulence determinants, in the plasmids.
The genes correlated with resistance and virulence are reported in Table 2.
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2.2. Biofilm Formation Detection
In this study, the K. pneumoniae isolate tested was considered a moderate biofilm producer.
The obtained values of optical density (OD) of negative control, cut-off, ST 405, and
two K. pneumoniae ATCC strains (ATCC 700603 and ATCC 13883 used as controls) are
reported in Table 3.
Table 2. Resistance genes and virulence factors detected by next-generation sequencing (NGS) analysis.
Resistance Genes
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Table 3. Optical density (O.D.) values.
OD 570
Negative control (median values) 0.059
Standard deviation 0.005
Cut-off (median values) 0.071
K. pneumoniae ST405 (median values) 0.215
ATCC 700603 (median values) 0.765
ATCC 13883 (median values) 0.102
3. Discussion
In summary, the retrospective WGS analysis of the K. pneumoniae isolate allowed us
to define a comprehensive overview of the genetic profile, which is useful for gaining
insights into the molecular characterization of antibiotic resistance, virulence potential, and
plasmid content [19].
The identified virulence determinants may have contributed to the bacterial attach-
ment/penetration and consequently to the infection and/or colonization severity of K. pneu-
moniae, which are very well adapted to their host environment.
The manifestation of adhesins is principally significant in the colonization phase,
when mechanical forces such as peristalsis and salivary secretions impede bacterial attack
of the host. The manifestation of type-3 fimbriae is known to be involved in biofilm
development on biotic and abiotic sides of medical devices in a hospital environment.
Capsules can also play a central role in Klebsiella spp. persistence inside and outside human
hosts by repelling complement-mediated lysis or phagocytosis and contributing some
defense against environmental dehydration. They may also have a counteracting effect
on antibodies as a result of the release of excessive capsular material. Iron scavenging is
significant in infections since hosts have little free iron under physiological settings, and
the existence of multiple iron acquisition systems may confirm optimal iron acquisition
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in diverse host environments. Microcin E492, a bacteriocin active against members of the
Enterobacteriaceae family, has been exposed to induce apoptosis in human cell lines, which
may offer a benefit during gastrointestinal colonization by helping selective environmental
fitness or playing a direct part in virulence [20,21].
Our results confirm that despite the in vitro resistance to the antibiotic therapy used,
the patient survived the infection thanks to the early use of combined therapy at high
doses of tigecycline and the immediate removal of the peripherally inserted central catheter
(PICC). Retrospective studies that also included patients with severe infections due to
K. pneumoniae (KPC-Kp) that produce blaKPC have also described the importance of early
onset of double and or triple combination therapy in reducing mortality at 14 days in
pan-resistant isolates [22,23].
Finally, other studies have suggested that a double combination of CS (Colistin) plus
TGC (Tigecycline) is synergic to reducing biofilms on in vitro catheter models, but only at
high concentrations of both drugs is TGC effective in the reduction of biofilm cells [24,25].
4. Materials and Methods
4.1. Patient Information, Bacterial Isolation, and Identification
The strain was isolated from a peripherally inserted central catheter (PICC) applied
in a 54-year-old female patient hospitalized in the University Hospital of Palermo, Italy,
in 2014. The patient signed an informed consent form before the recovery.
The patient was admitted for emergency surgery on 16 September 2013, for colon
surgery; after 18 days, she was transferred to the intensive care unit until 18 March
2014, when she was transferred to the internal medicine unit. After 5 days, a strain of K.
pneumoniae was isolated from the PICC.
The same strain was isolated from all blood cultures performed.
At this time, K. pneumoniae sequence type (ST) 258 producing K. pneumoniae carbapen-
emase (KPC-Kp) bloodstream infection was reported in postoperative abdominal surgery
patients [26]. Therefore, due to the patient’s critical condition and suspicion of surgical
complication, an empiric double combination antibiotic treatment with high-dose tigecy-
cline (100 mg every 12 h) and colistin at a dosage of 5 mg/kg/day divided in three equal
doses was started, the PICC was removed, and a susceptibility test was requested. The
patient was discharged on 13 May 2014.
A Becton-Dickinson Phoenix™ automated system (Becton Dickinson, Sparks, MD,
USA) was used for species and antimicrobial susceptibility tests. Susceptibility profiles
were understood according to the European Committee on Antimicrobial Susceptibility
Testing breakpoints criteria, while susceptibility to colistin and tigecycline was confirmed
by the MicroScan system (Beckman Coulter, Inc., Brea, CA, USA).
The strain showed resistance to multiple clinically used antibiotics: beta-lactams,
aminoglycosides, antipseudomonal penicillin and beta-lactamase inhibitors, extended and
non-extended spectrum cephalosporins, fluoroquinolones, sulfonamides, monobactams,
penicillin and beta-lactamase inhibitors, antipseudomonal fluoroquinolones, and colistin.
The isolate showed susceptibility for only tigecycline, as shown in Table 4.
4.2. Molecular Genotyping
The bacteria grown on blood agar for 18 h were used for the DNA extraction and for
sequencing using the QIAmp® DNA Mini kit Qiagen (QIAGEN GmbH, Hilden, Germany).
A NanoDrop 8000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) was
used to analyze the quantity and purity of the DNA.
A Nextera XT Library Prep Kit (Illumina, San Diego, CA, USA) was used for library
preparation and a NextSeq Mid-Output kit v2 (300-cycles) for sequencing on a NextSeq
500 platform (Illumina). The sequencing generated 3,534,792 paired-end reads checked for
quality using FASTQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/,
accessed on 10 May 2021), trimmed with Sickle (https://github.com/najoshi/sickle, ac-
cessed on 10 May 2021), and assembled using SPAdes V3.7.0 [27]. The assembly yielded
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207 contigs >500 bp with 137-fold coverage. The submitted sequences have a combined
length of 5,571,183 bp with a G + C content of 58% and an N50 of 82,335 nucleotides. The
contiguous sequences were annotated using the NCBI Prokaryotic Genomes Automatic
Annotation Pipeline (PGAAP; http://www.ncbi.nim.nih.gov/genome/annotation_prok/,
accessed on 10 May 2021).



















MIC: minimal inhibitory concentration; IMI: imipenem; MEP: meropenem; ETP: ertapenem; CIP: ciprofloxacin;
AUG: amoxicillin/clavulanic acid; CXM: cefuroxime; CTX: cefotaxime; CAZ: ceftazidime; FEP: cefepime; SXT:
trimethoprim-sulfamethoxazole; CN: gentamycin; ATM: aztreonam; TZP: piperacillin/tazobactam; FOS: fos-
fomycin c/G6P; TGC: tigecycline; CS: colistin.
The BIGSdb-Kp database (http://bigsdb.web.pasteur.fr/klebsiella/klebsiella.html,
accessed on 10 May 2021) was used to conduct multilocus sequence typing (MLST) analysis
and to define antibiotic resistance and virulence-related mechanisms.
Phyloviz software based on the goeBURST algorithm was used to visualize the evolu-
tionary relationships among the isolates [28,29].
The PlasmidFinder-1.3 web tool (Center for Genomic Epidemiology, Lyngby, Denmark;
http://www.genomicepidemiology.org (accessed on 10 May 2021); ID 95%) was used to
define the replicon plasmid content type.
4.3. Quantitative Biofilm Production Assay
Three wells of a 96-well flat-bottomed plastic tissue culture plate were filled with
180 µL of Luria–Bertani (LB) supplemented with 1% glucose and 20 µL of overnight culture
diluted to a final optical density of 600 (OD 600) = 0·1 were used for quantification of biofilm
production. As a negative control, sterile LB supplemented with 1% glucose was used,
while the strain type K. pneumoniae ATCC 13883 was selected as positive control. After
incubation at 37 ◦C for 18 h, each well was washed three times with PBS, dehydrated for 1 h
at 60 ◦C, and marked for 15 min with 180 µL of 2% Hucker’s crystal violet (Sigma-Aldrich
Corporation, St. Louis, MO, USA). The dye bound to the adherent cells was solubilized
with 180 µL of 33% (v/v) glacial acetic acid, and the absorbance was measured at 570 nm
(OD 570). The assay was done in triplicate and repeated four times [30,31].
The OD cut-off (ODc) was defined as three standard deviations above the mean OD
of the negative control.
The ability of biofilm formation was evaluated on the basis of the adherence capa-
bilities into the following categories: non-biofilm producers (OD ≤ ODc), weak biofilm
producers (ODc < OD≤ 2×ODc), moderate biofilm producers (2×ODc < OD≤ 4 × ODc),
and strong biofilm producers (4 × ODc < OD).
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5. Conclusions
In conclusion, the routine clinical implementation of real-time WGS and evaluation
of the ability to produce biofilm in hospital settings would help to surveil nosocomial
pathogens and alert clinicians to their presence. This would provide well-founded and
punctual data on the emergence and spread of antibiotic resistance with the consequent pos-
sibility of preventing outbreaks by applying infection control procedures and implementing
a targeted antimicrobial stewardship program. The enhancement of the surveillance pro-
gram is even more essential in the case of strains with antibiotic resistance and virulence
factor co-existence that could lead to life-threatening, untreatable, and invasive infections.
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